Inactive

See Attached Combined Synopsis/Solicitation FDA_22-223-NCTR-2022-112051 As required therein at provision FAR 52.212-1 - Instructions to Offerors, Paragraph (j) Unique Entity Identifier Offerors shall ... See Attached Combined Synopsis/Solicitation FDA_22-223-NCTR-2022-112051 As required therein at provision FAR 52.212-1 - Instructions to Offerors, Paragraph (j) Unique Entity Identifier Offerors shall include the firm’s Unique Entity Identifier number with their proposal/quote. The Unique Entity Identifier has replaced the previously used DUNS Number.